en
Scientific article
Open access
English

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose

Published inInternational journal of radiation oncology, biology, physics, vol. 59, no. 5, p. 1295-1300
Publication date2004
Abstract

Tumor uptake of 2-[(18)F] fluoro-2-deoxy-D-glucose (FDG) may relate to outcome in cancer patients. Pretreatment FDG uptake was evaluated as a predictor of local control (LC) and disease-free survival (DFS) in patients with head-and-neck cancer managed primarily either by radiotherapy (RT) or surgery.

Keywords
  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Combined Modality Therapy
  • Female
  • Fluorodeoxyglucose F18/diagnostic use/pharmacokinetics
  • Head and Neck Neoplasms/pathology/radionuclide imaging/radiotherapy/surgery
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Prospective Studies
  • Radiopharmaceuticals/diagnostic use/pharmacokinetics
  • Tomography, Emission-Computed
  • Treatment Outcome
Citation (ISO format)
ALLAL, Abdelkarim Said et al. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. In: International journal of radiation oncology, biology, physics, 2004, vol. 59, n° 5, p. 1295–1300. doi: 10.1016/j.ijrobp.2003.12.039
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0360-3016
559views
406downloads

Technical informations

Creation10/28/2013 8:20:00 PM
First validation10/28/2013 8:20:00 PM
Update time03/14/2023 8:50:08 PM
Status update03/14/2023 8:50:07 PM
Last indexation01/16/2024 8:50:20 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack